Cancer Science

Papers
(The H4-Index of Cancer Science is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes239
Reactive oxygen species in cancer: Current findings and future directions226
Tumor microenvironment in gastric cancers160
Tumor immune microenvironment and immune checkpoint inhibitors in esophageal squamous cell carcinoma143
Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes133
Pyroptosis, a new bridge to tumor immunity110
Heterogeneity of cancer‐associated fibroblasts: Opportunities for precision medicine101
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer93
Ferroptosis at the crossroads of infection, aging and cancer85
Circular RNA LPAR3 sponges microRNA‐198 to facilitate esophageal cancer migration, invasion, and metastasis84
CAR‐NK cell in cancer immunotherapy; A promising frontier83
TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation81
Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors73
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer72
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells70
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2‐targeting Ab–drug conjugate, in monkeys67
Relationship among DNA double‐strand break (DSB), DSB repair, and transcription prevents genome instability and cancer66
Ferroptosis‐related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma65
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma65
Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression61
A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström’s macroglobulinemia60
Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy58
Functional diversity of cancer‐associated fibroblasts in modulating drug resistance55
Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer53
RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma52
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial50
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota49
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes47
Tumor‐homing peptide and its utility for advanced cancer medicine47
The roles and regulation of the KLF5 transcription factor in cancers47
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration45
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer45
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab44
Amino acid transporters as emerging therapeutic targets in cancer44
Nuclear microenvironment in cancer: Control through liquid‐liquid phase separation44
The gut microbiota associated with high‐Gleason prostate cancer43
RNA‐dependent RNA polymerase, RdRP, a promising therapeutic target for cancer and potentially COVID‐1942
Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single‐arm study42
IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism41
Immune infiltration profiling in gastric cancer and their clinical implications41
The noncanonical role of EZH2 in cancer41
0.055897951126099